70324-97-9

Upstream product

• 6340-79-0 4-oxo-4-(4-bromophenyl)butanoic acid 

Downstream Products

• 1254102-24-3 benzyl 4-(3-amino-4-phenylphenyl)butyrate tosylate 
• 1254102-25-4 benzyl 4-[3-({[(1-methylpiperidin-4-yl)oxy]carbonyl}amino)-4-phenylphenyl]butyrate 
• 70348-73-1 4-(3-amino-4-bromophenyl)-4-oxobutanoic acid 
• 70325-02-9 4-(4-bromo-3-sulfamoylphenyl)-4-oxobutanoic acid methylamide 
• 70325-00-7 methyl 4-(4-bromo-3-sulfamoylphenyl)-4-oxobutanoate 
• 70324-98-0 4-(4-bromo-3-chlorosulfonylphenyl)-4-oxobutanoic acid 
• 70324-99-1 4-(4-Bromo-3-sulfamoyl-phenyl)-4-oxo-butyric acid 

Relevant academic research and scientific papers

QUATERNARY AMMONIUM SALT COMPOUNDS

[Problem] The object of the present invention is to provide a novel compound having 132 adrenergic receptor agonist activity and muscarinic receptor antagonist activity. [Means for Solving the Problem] The present invention is a quaternary ammonium salt compounds represented by formula (I), or a pharmaceutically acceptable salt thereof, with superior β32 adrenergic receptor agonist activity and muscarinic receptor antagonist activity.

3-(3-(3-SUBSTITUTED AMINO-2-HYDROXYPROPOXY)PHENYL)-6-HYDRAZINO PYRIDAZINES AND THEIR USE AS VASODILATORS AND BETA-ADRENERGIC BLOCKING AGENTS

The compounds are 3-(3-(3-substituted amino-2-hydroxypropoxy) phenyl)-6-hydrazino pyridazines which have β-adrenergic blocking and vasodilator activity.